R&D Partner Content 8th Dermatology Drug Development Summit Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
R&D Partner Content 9th CDD For Biologics Summit 2024 Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development
R&D Partner Content Targeted Radiopharmaceuticals Summit EU 2024 Taking place in Amsterdam 3rd- 5th December! With 40+ new speakers, 2 tracks of content (pre-clinical and clinical), a deep dive workshop day
R&D Partner Content 7th RNA-Targeted Drug Discovery & Development Summit Optimizing Lead Discovery, Structural Analysis & Preclinical Modeling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation
R&D Partner Content 4th Mitochondrial Dysfunction Drug Development Summit Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success
R&D Partner Content 8th Annual Complement-Based Drug Development Summit Achieving Efficacy & Exploring Indication Expansion for Complement Inhibitors
News NICE turns down Takeda colorectal cancer drug Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the grounds that it is not cost-effective.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
